Synthesis, characterization, and tumor selectivity of a polyphosphazene-platinum(II) conjugate
- Authors
- Song, R; Jun, YJ; Kim, JI; Jin, C; Sohn, YS
- Issue Date
- 2005-06-20
- Publisher
- ELSEVIER SCIENCE BV
- Citation
- JOURNAL OF CONTROLLED RELEASE, v.105, no.1-2, pp.142 - 150
- Abstract
- A new amphiphilic poly(organophosphazene) was synthesized by stepwise nucleophilic substitutions with a hydrophilic methoxy poly(ethylene glycol) with an average molecular weight of 350 (MPEG350) and a hydrophobic glyCyl-L-glutamate as side groups, and then an antitumor (dach)platinum(II) (dach: trans -(+/-)- 1,2-diaminocyclohexane) moiety was conjugated to the polymer using the dipeptide as a spacer. This polymeric platinum conjugate was found to be accumulated in the tumor tissue to a remarkably greater extent than in the normal tissue (tumor/tissue ratio > 4), probably due to the excellent EPR effect and the long circulating properties of the polymer conjugate (t(1/2 beta)=6.2 h and AUC=4020 nmol h/ml) compared with carboplatin ((1/2 beta) =0.42 h and AUC=120 nmol h/ml). The polymer conjugate also exhibited high in vitro cytotoxicity comparable to cisplatin against several human tumor cells tested. (c) 2005 Elsevier B.V. All rights reserved.
- Keywords
- VASCULAR-PERMEABILITY; ANTITUMOR-ACTIVITY; MOLECULAR-WEIGHT; DRUG-DELIVERY; LIPOSOME SIZE; COMPLEXES; POLYMERS; BIODISTRIBUTION; ELECTROLYTES; THERAPEUTICS; VASCULAR-PERMEABILITY; ANTITUMOR-ACTIVITY; MOLECULAR-WEIGHT; DRUG-DELIVERY; LIPOSOME SIZE; COMPLEXES; POLYMERS; BIODISTRIBUTION; ELECTROLYTES; THERAPEUTICS; polyphosphazene; platinum conjugate; anticancer drug; tumor selectivity
- ISSN
- 0168-3659
- URI
- https://pubs.kist.re.kr/handle/201004/136356
- DOI
- 10.1016/j.jconrel.2005.03.016
- Appears in Collections:
- KIST Article > 2005
- Files in This Item:
There are no files associated with this item.
- Export
- RIS (EndNote)
- XLS (Excel)
- XML
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.